Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety and efficacy of treatment with the Liposonix System (Model 2) for the circumferential reduction of subcutaneous adipose tissue (SAT) of the thighs.


Clinical Trial Description

Subjects received a single treatment (Liposonix System) on one randomly assigned thigh. The opposite thigh was not treated and served as a control for each subject. ;


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Treatment of Adipose Tissue in the Thighs

NCT number NCT01823653
Study type Interventional
Source Valeant Pharmaceuticals
Contact
Status Completed
Phase N/A
Start date July 2012
Completion date January 2013